Atricure Share Price Today
(NASDAQ: ATRC)

Name: Atricure Share Price Today (NASDAQ: ATRC) - Atricure Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Atricure share price is $37.85 & ₹3,291.78 as on 6 Mar 2025, 2.30 'hrs' IST

$37.85

▲

-0.31

(-0.81%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Atricure share price in Dollar and Rupees. Guide to invest in Atricure stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atricure, along with analyst recommendations, forecasts, and comprehensive financials.

Atricure share price movements

Today's Low: $37.63
Today's High: $38.60
$37.85
0.58%
Downside
Day's Volatility :2.5%
Upside
1.93%
52 Weeks Low: $18.94
52 Weeks High: $43.11
$37.85
49.96%
Downside
52 Weeks Volatility :56.07%
Upside
12.2%

Atricure (ATRC) Returns

Period	Atricure Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	11.87%	2.1%	0.0%
6 Months	45.98%	-4.1%	0.0%
1 Year	1.06%	2.2%	0.0%
3 Years	-40.8%	11.8%	-11.6%

Atricure (ATRC) Key Statistics

in dollars & INR

Previous Close	$38.16
Open	$37.98
Today's High	$38.595
Today's Low	$37.63
Market Capitalization	$1.9B
Today's Volume	$134.2K
52 Week High	$43.11
52 Week Low	$18.94
Revenue TTM	$465.3M
EBITDA	$-21.3M
Earnings Per Share (EPS)	$-0.95
Profit Margin	-9.61%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-9.64%

How to invest in Atricure Stock (ATRC) from India?

It is very easy for Indian residents to invest directly in Atricure from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atricure stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atricure or ATRC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atricure or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atricure shares which would translate to 0.023 fractional shares of Atricure as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atricure, in just a few clicks!

Returns in Atricure (ATRC) for Indian investors in Rupees

The Atricure stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Atricure investment value today

Current value as on today

₹1,05,201

Returns

₹5,201

(+5.2%)

Returns from Atricure Stock

₹238 (+0.24%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Atricure (ATRC)

-80%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Atricure Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Atricure

Vanguard Group Inc
9.52%
BlackRock Inc
8.82%
AllianceBernstein L.P.
7.85%
Hood River Capital Management LLC
5.98%
Champlain Investment Partners, LLC
5.17%
Macquarie Group Ltd
4.86%

Analyst Recommendation on Atricure

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Atricure(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Atricure Stock (ATRC)

What analysts predicted

Upside of 43.26%

Target:

$54.22

Current:

$37.85

Insights on Atricure Stock (Ticker Symbol: ATRC)

Price Movement
In the last 6 months, ATRC stock has moved up by 46.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 115.91M → 124.27M (in $), with an average increase of 6.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.85M → -15.56M (in $), with an average decrease of 98.2% per quarter
ATRC vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 44.1% return, outperforming this stock by 43.1%
ATRC vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 84.6% return, outperforming this stock by 128.0%
Price to Sales
ForATRC every $1 of sales, investors are willing to pay $3.9, whereas for Intuitive Surgical, Inc., the investors are paying $23.7 for every $1 of sales.

Atricure Technicals Summary

Sell

Neutral

Buy

Atricure is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Atricure (ATRC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Atricure Inc	-3.88%	45.98%	1.06%	-40.8%	7.19%
Intuitive Surgical, Inc.	-3.56%	17.05%	43.74%	90.63%	227.79%
Alcon Ag	2.42%	-1.93%	7.98%	27.22%	63.47%
Resmed Inc.	-3.77%	-5.43%	25.61%	-6.39%	49.83%
Becton, Dickinson And Company	-9.43%	-3.85%	-4.81%	-18.76%	-2.82%
Cooper Companies Inc., The	-4.9%	-14.86%	-10.99%	-9.6%	14.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Atricure Inc	34.48	NA	-1.18	-0.58	-0.1	-0.04	NA	9.43
Intuitive Surgical, Inc.	88.31	88.31	3.96	8.06	0.16	0.09	NA	46.08
Alcon Ag	45.92	45.92	2.8	3.27	0.05	0.03	0.0	43.58
Resmed Inc.	27.49	27.49	1.67	9.47	0.26	0.14	0.01	35.77
Becton, Dickinson And Company	38.47	38.47	1.04	14.42	0.07	0.04	0.02	87.78
Cooper Companies Inc., The	46.76	46.76	9.46	3.98	0.05	0.04	NA	40.5

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Atricure Inc	Buy	$1.9B	7.19%	34.48	-9.61%
Intuitive Surgical, Inc.	Buy	$202.2B	227.79%	88.31	27.81%
Alcon Ag	Buy	$46.6B	63.47%	45.92	10.27%
Resmed Inc.	Buy	$34.2B	49.83%	27.49	25.35%
Becton, Dickinson And Company	Buy	$64.4B	-2.82%	38.47	8.37%
Cooper Companies Inc., The	Buy	$18.3B	14.23%	46.76	10.07%

About Atricure

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Organization	Atricure
Employees	1300
CEO	Mr. Michael H. Carrel
Industry	Health Technology

Management People of Atricure

Name	Title
Mr. Michael H. Carrel	CEO, President & Director
Ms. Angela L. Wirick	Chief Financial Officer
Mr. Douglas J. Seith	Chief Operating Officer
Mr. Salvatore Privitera J.D.	Chief Technical Officer
Mr. Karl S. Dahlquist CCEP, J.D.	Chief Legal Officer
Dr. Vinayak Doraiswamy Ph.D.	Chief Scientific Officer
Valerie Storch-Willhaus	Vice President of Corporate Marketing & Communications
Mr. Justin J. Noznesky	Chief Marketing & Strategy Officer
Ms. Deborah Yount	Chief Human Resources Officer

Important FAQs about investing in ATRC Stock from India :

What is Atricure share price today?

Atricure share price today stands at $37.85, Open: $37.98 ; Previous Close: $38.16 ; High: $38.60 ; Low: $37.63 ; 52 Week High: $43.11 ; 52 Week Low: $18.94.

The stock opens at $37.98, after a previous close of $38.16. The stock reached a daily high of $38.60 and a low of $37.63, with a 52-week high of $43.11 and a 52-week low of $18.94.

Can Indians buy Atricure shares?

Yes, Indians can invest in the Atricure (ATRC) from India.

With INDmoney, you can buy Atricure at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Atricure at zero transaction cost.

How can I buy Atricure shares from India?

It is very easy to buy Atricure from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atricure (ATRC) be purchased?

Yes, you can buy fractional shares of Atricure with INDmoney app.

What are the documents required to start investing in Atricure stocks?

To start investing in Atricure, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.